ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

VANIQA
Miscellaneous dermatological conditions
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

VANIQA Rx

Generic Name and Formulations:
Eflornithine HCl 13.9%; crm.

Company:
Allergan

Therapeutic Use:

Indications for VANIQA:

Reduction of unwanted facial hair in women.

Adult:

Apply a thin layer to affected areas of face and adjacent areas under the chin twice daily at least 8 hours apart; rub in thoroughly. Do not wash treated area for at least 4 hours. Continue to use hair removal techniques as needed. May apply cosmetics or sunscreens after cream dries.

Children:

Not recommended.

Warnings/Precautions:

Reduce frequency if irritation or intolerance develops; discontinue if irritation continues. Abraded or broken skin. Pregnancy (Cat.C): not recommended. Nursing mothers.

Pharmacological Class:

Hair growth retardant.

Adverse Reactions:

Acne, pseudofolliculitis barbae, stinging, headache, burning, dry skin, erythema, tingling, dyspepsia, irritation, rash, alopecia, dizziness.

How Supplied:

Crm—30g, 60g (2x30g)

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs